Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 423-340-5 | CAS number: 162881-26-7 CGI 819
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study conducted according to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (1987)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
- EC Number:
- 423-340-5
- EC Name:
- Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
- Cas Number:
- 162881-26-7
- Molecular formula:
- C26 H27 O3 P
- IUPAC Name:
- [phenyl(2,4,6-trimethylbenzoyl)phosphoryl](2,4,6-trimethylphenyl)methanone
- Details on test material:
- - Name of test material (as cited in study report): TKA 40135 (CGI 819)
Constituent 1
Method
- Target gene:
- histidine or tryptophan auxotrophy
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- other: defect in the excision repair system (uvrB) , presence of rfa character
- Species / strain / cell type:
- S. typhimurium TA 102
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- other: defect in the excision repair system (uvrB) , presence of rfa character, AT base pair at the primary reversion site
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- other: AT base pair at the primary reversion site , DNA repair-proficient
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-fraction obtained from the liver of male sprague-dawley rats treated with AROCLOR 1254, mixed with a series of cofactors (MgCl2, KCl, glucose-6-phosphate, NADP, phosphate buffer)
- Test concentrations with justification for top dose:
- Range-finding test: 20.6 - 5000 µg/plate
Main test: 312.5 - 5000 µg/plate
Confirmation: 312.5 - 5000 µg/plate - Vehicle / solvent:
- DMSO was used as vehicle since the test substance was soluble up to the concentration of 50 mg/mL in this vehicle.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- see solvent control
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- with S9-mix
- Positive control substance:
- other: 2-aminoanthracene (2-AA)
- Remarks:
- in DMSO at 1.5 µg/plate in TA 100, TA 1537, TA 98; in DMSO at 5.0 µg/plate in TA 102; in DMSO at 20 µg/plate in E. coli
- Positive controls:
- yes
- Remarks:
- with S9 mix
- Positive control substance:
- cyclophosphamide
- Remarks:
- in bidistilled water at 200 µg/plate in TA 1535
- Positive controls:
- yes
- Remarks:
- without S9-mix
- Positive control substance:
- sodium azide
- Remarks:
- in bidistilled water at 2 µg/plate in TA 100 and TA 1535
- Positive controls:
- yes
- Remarks:
- without S9-mix
- Positive control substance:
- other: 4-Nitroquinoline
- Remarks:
- in DMSO at 2 µg/plate in E. coli
- Positive controls:
- yes
- Remarks:
- without S9-mix
- Positive control substance:
- mitomycin C
- Remarks:
- in bidistilled water at 0.5 µg/plate in TA 102
- Positive controls:
- yes
- Remarks:
- without S9-mix
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- in DMSO at 5 µg/plate in TA 98
- Positive controls:
- yes
- Remarks:
- without S9-mix
- Positive control substance:
- 9-aminoacridine
- Remarks:
- in DMSO at 80 µg/plate in TA 1537
- Details on test system and experimental conditions:
- PREPARATION OF THE TEST SOLUTIONS
The test material was dissolved in the dark in DMSO after slightly warmed up. The test substance was soluble up to the concentration of 50 mg/ml. Lower concentrations of the test substance were obtained by appropriate dilution of the stock solution with DMSO. The test
substance and the solutions were handled in darkness unter red light. No precipitates or aggregates were noted.
METHOD OF APPLICATION
Standard plate incorporation assay:
0.1 mL of the overnight cultures were mixed with 2 mL of top agar, either 0.5 mL of 100 mM sodium phosphate buffer (experiments without activation) or 0.5 mL of S9-mix (experiments with activation) and 0.1 mL of test solution, positive control or the solvent as negative control. The mixture was poured on minimal agar in Petri dishes.
Preincubation assay:
0.1 mL of the overnight cultures were mixed with 0.5 mL of S9-mix (experiments with activation) and 0.1 mL of test solution, positive control or the solvent as negative control. The mixture was incubated for 30 minutes at 37°C. Thereafter 2 mL of top agar were added to the mixture, which was then poured on minimal agar in Petri dishes.
Each Petri dish contained about 20.0 mL of minimal agar; the top agar was composed of 0.6% agar and 0.6% NaCl.
In the Salmonella experiment, the top agar was supplemented with 10% of 0.5 mM L-histidine and 0.5 mM d-biotin dissolved in water.
In the experiment with E. coli, the top agar was supplemented with 10% of 0.5 mM L-tryptophan dissolved in water.
RANGE FINDER
The range finding test was carried out with TA 100 and E. coli WP2 uvrA with and without S9-mix at six concentrations of the test substance and one negative control; the highest concentration applied was 5000 µg/plate. The plates were inverted and incubated for about 48 hours at 37±1.5°C in darkness. Thereafter, they were evaluated by counting the colonies and determining the background lawn. One plate per test substance concentration and negative control was used.
MAIN MUTAGENICITY TEST
The main mutagenicity test was performed with all strains mentioned above with and without S9-mix. Each of the five selected concentrations of the test substance, a negative and a positive control, were tested using three plates per test concentration. The highest concentration applied had been determined in the preliminary range finder. The plates were inverted and incubated for about 48 hours at 37±1.5°C in darkness. Thereafter, they were evaluated by counting the number of colonies and determining the background lawn.
CONFIRMATORY TEST
The conduct of the confirmatory was similar to that of the main test described above.
COLONY COUNTING AND SCORING OF THE PLATES
Colonies were counted electronically (Artek Colony Counter), or manually where minor agar damage or test chemical precipitates or strong coloration of the agar plates might have interfered with automating counting. The means for all mutagenicity assays were calculated. - Evaluation criteria:
- Generally a concentration-related effect should be demonstrable. The test chemical is considered positive if the following criteria are met:
- At least a reproducible doubling of the mean number of revertants per plate above that of the negative control at any concentration for one or more of the following strains: TA 98, TA 1535, TA 1537, E. coli WP2 uvrA.
- A reproducible increase of the mean number of revertants per plate for any concentration above that of the negative control by at least a factor of 1.5 for strains TA 100 or TA 102.
- Statistics:
- A statistical analysis was not performed.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- other: S. typhimurium TA 1535, TA 1537, TA 98, TA 100, TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- no increase in the incidence of revertants was observed in any of the Salmonella strains tested.
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- In fact, a growth inhibiting effect in absence of S9-mix was reported for strain TA 98 since the number of revertants was weakly reduced at the concentration of 5000 µg/plate; this effect was not observed with the other strains with and without S9-mix.
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- other: see solvent control
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- no increase in the incidence of revertants was observed.
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- other: see solvent control
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDER
Normal background growth was observed with both strains. The numbers of revertant colonies were not reduced. At the concentrations of 185.2 µg/plate and above the test substance precipitated on the surface of the agar plates. From the results obtained, the highest concentration suitable for the mutagenicity test was selected to be 5000 µg/plate with and without metabolic activation.
CONFIRMATORY TEST
In the confirmatory experiments performed with and without metabolic activation, again after treatment of strains TA 98, TA 100, TA 102, TA 1535, TA 1537 and WP2 uvrA with the test material, no increase in the incidence of either histidine- or tryptophan-prototrophic mutants was observed in comparison with the negative control.
PRECIPITATION
At the concentrations of 625 µg/plate and above the test substance precipitated on the surface of the agar plates. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
MAIN MUTAGENICITY TEST – SUMMARY OF RESULTS:
Main Mutagenicity Test without S9-mix |
||||||
Concentration (µg/plate) |
Tester Strain |
|||||
TA100 |
TA1535 |
TA98 |
TA1537 |
TA102 |
E. coli WP2 uvra |
|
Solvent control |
105.33 |
15.33 |
25.33 |
11.67 |
176 |
17 |
312.5 |
118.33 |
17 |
28.33 |
12 |
162.33 |
16 |
625 |
104.33 |
13 |
25.67 |
12.33 |
144.33 |
19 |
1250 |
107.33 |
13 |
26 |
13 |
124 |
18.33 |
2500 |
115.33 |
15.67 |
18.67 |
12 |
128.33 |
15.67 |
5000 |
105.33 |
16.67 |
10.67 |
9 |
126.33 |
17.33 |
Positive control |
817 |
729.67 |
1042.33 |
1409 |
781.67 |
821.67 |
Main Mutagenicity Test with S9-mix |
||||||
Concentration (µg/plate) |
Tester Strain |
|||||
TA100 |
TA1535 |
TA98 |
TA1537 |
TA102 |
E. coli WP2 uvra |
|
Solvent control |
147 |
14 |
52.33 |
8.33 |
272.33 |
25.67 |
312.5 |
135.67 |
15.67 |
45 |
10.33 |
281.33 |
26.67 |
625 |
136 |
13.33 |
36.33 |
11 |
251 |
26.33 |
1250 |
133.67 |
17.33 |
42.67 |
11.67 |
238.67 |
23.33 |
2500 |
140.67 |
9.67 |
48.67 |
9.33 |
212 |
25 |
5000 |
124.33 |
11.67 |
40 |
11 |
191.33 |
22.67 |
Positive control |
1243.67 |
264.67 |
1161 |
163.67 |
949 |
646 |
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.